...
首页> 外文期刊>Chemical Society Reviews >Optical nano-agents in the second near-infrared window for biomedical applications
【24h】

Optical nano-agents in the second near-infrared window for biomedical applications

机译:用于生物医学应用的第二近红外窗口中的光学纳米剂

获取原文
获取原文并翻译 | 示例
           

摘要

The optical technology presents non-invasive, non-destructive, and non-ionizing features and has the ability to display various chemical components in tissues to provide useful information for various biomedical applications. Regarding selection of light wavelengths, second near-infrared (NIR-II, 900-1700 nm) light is a much better choice compared to both visible (380-780 nm) and traditional near-infrared (780-900 nm) light, because of its advantages including deeper penetration into biological tissues, less tissue scattering or absorption, and decreased interference by fluorescent proteins. Thus, using optical nano-agents that absorb or emit light in the NIR-II window can achieve deeper tissue optical imaging with higher signal-to-background ratios and better spatial resolution for diagnosis. What's more, some of these nano-agents can be further applied for imaging guided surgical removal, real-time monitoring of drug delivery, labeling lymphatic metastasis, biosensing, and imaging guided phototherapy. In this review, we attempt to summarize the recent advances of various NIR-II nano-agents (including single-walled carbon nanotubes, quantum dots, rare-earth doped nanoparticles, other inorganic nanomaterials, small organic molecule-based nanoparticles, and semiconducting polymer nanoparticles) in both bioimaging and therapeutic applications, and discuss the challenges and perspectives of these nano-agents for clinical practice in the near future.
机译:光学技术呈现非侵入性,非破坏性和非电离特征,并且能够在组织中显示各种化学成分,以提供各种生物医学应用的有用信息。关于光波长的选择,与可见(380-780nm)和传统的近红外(780-900nm)光相比,第二近红外(NIR-II,900-1700nm)光是更好的选择,因为其优点包括更深入地渗透到生物组织中,减少组织散射或吸收,并通过荧光蛋白的干扰减少。因此,使用在NIR-II窗口中吸收或发射光的光学纳米试剂可以通过更高的信号 - 背景比率和更好的空间分辨率来实现更深入的组织光学成像和用于诊断的更好的空间分辨率。更重要的是,这些纳米药物中的一些可以进一步应用于成像引导的手术移除,实时监测药物递送,标记淋巴结转移,生物传感和成像引导光疗法。在本文中,我们试图总结各种NIR-II纳米试剂的最近进程(包括单壁碳纳米管,量子点,稀土掺杂纳米颗粒,其他无机纳米材料,基于小型有机分子的纳米颗粒和半导体聚合物纳米颗粒)在生物体和治疗应用中,并讨论了这些纳米药物在不久的将来临床实践的挑战和观点。

著录项

  • 来源
    《Chemical Society Reviews》 |2019年第1期|共16页
  • 作者单位

    Nanjing Univ Med Sch Nanjing Stomatol Hosp Cent Lab Stomatol 30 Zhongyang Rd Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Med Sch Nanjing Stomatol Hosp Cent Lab Stomatol 30 Zhongyang Rd Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Med Sch Nanjing Stomatol Hosp Cent Lab Stomatol 30 Zhongyang Rd Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Med Sch Nanjing Stomatol Hosp Cent Lab Stomatol 30 Zhongyang Rd Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Univ Med Sch Nanjing Stomatol Hosp Cent Lab Stomatol 30 Zhongyang Rd Nanjing 210008 Jiangsu Peoples R China;

    Nanjing Tech Univ NanjingTech Key Lab Flexible Elect KLOFE 30 South Puzhu Rd Nanjing 211800 Jiangsu Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号